Comparison of Lung Deposition With the Aeroneb Solo Adapter and a Standard Jet Nebulizer by SPECT-CT

• Register: ClinicalTrials.gov
• Last refreshed on: 7 December 2015
• Main ID: NCT02298101
• Date of registration: 19/11/2014
• Prospective Registration: No
• Primary sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
• Public title: Comparison of Lung Deposition With the Aeroneb Solo Adapter and a Standard Jet Nebulizer by SPECT-CT
• Date of first enrolment: September 2014
• Target sample size: 6
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02298101
• Study type: Interventional
• Study design: Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment
• Phase: N/A

Countries of recruitment

Belgium

Key inclusion & exclusion criteria

Inclusion Criteria:

- Healthy respiratory function

Exclusion Criteria:

- Pulmonary disease



Age minimum: 18 Years
Age maximum: 90 Years
Gender: Male

Health Condition(s) or Problem(s) studied

Healthy

Intervention(s)

Device: Aeroneb Solo Adapter

Other: Spirometry

Other: Planar scintigraphy

Other: Single photon emission computed tomography

Drug: Technetium-99m - Diethylenetriaminepentaacetic acid

Device: Opti-Mist Plus Nebulizer

Primary Outcome(s)

Pulmonary deposition [Time Frame: immediately after nebulization by imaging assessment, an expected average of 15 minutes]

Secondary Outcome(s)

Three-dimensional penetration index [Time Frame: immediately after the nebulization by imaging assessment, expected average of 30 minutes]

Secondary ID(s)

AeroSpect-01

Source(s) of Monetary Support

Please refer to primary and secondary sponsors